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ABSTRACT
Minimally invasive procedures such as percutaneous
cementoplasty can provide immediate pain relief and
can restore mechanical stability for patients with bone
metastases who are not candidates for surgery or who
show resistance to radiotherapy or analgesic treat-
ment. Here, we examine a case of percutaneous
cementoplasty to treat a lytic lesion of the acetabu-
lum from breast cancer. Good filling was observed,
and no complications occurred. A research assistant
recorded the patient’s scores on the Karnofsky Per-
formance Scale, Townsend Functional Assessment
Scale, and Brief Pain Inventory before surgery and
at days 1, 2, and 4 and weeks 1, 2, and 4 post-proce-
dure. Improvement in pain and walking ability was
demonstrated within the first 48 hours of treatment,
and that improvement remained constant throughout
follow-up. These findings echo the literature, in that
percutaneous cementoplasty provides immediate and
long-term pain relief with few complications. We rec-
ommend that percutaneous cementoplasty be used as
an additional tool for palliative treatment of patients
with bone metastases.
KEY WORDS
Percutaneous cementoplasty, bone metastases,
cancer
1. INTRODUCTION
Bone metastases are a frequent complication in on-
cologic patients, often affecting the acetabulum and
producing significant pain and disability 1. Surgery
is the treatment of choice for acetabular lesions 2, but
the surgery can be technically difficult when the me-
tastasis is extensive 1. Palliative radiotherapy has been
shown to be effective in relieving pain from bone
metastases 3; however, some patients do not respond 4,
and the delay from treatment to bone strengthening
may prove too lengthy for patients with extensive
lytic lesions 2. Analgesics can adequately control pain
in 80% of advanced cancer patients, but systemic
therapies are not without side effects 5. In situations
with architectural distortion and in patients deemed
not suitable for open surgery, minimally invasive pro-
cedures such as percutaneous vertebroplasty and
cementoplasty can provide immediate pain relief and
can restore mechanical stability. Here, we report a
case of a lytic metastasis in the left acetabulum from
breast cancer; the metastasis was treated with percu-
taneous cementoplasty after administration of pallia-
tive radiotherapy.
2. CASE STUDY
An 80-year-old woman was treated with a modified
radical mastectomy for stage I breast cancer in 1979.
She developed chest wall recurrences in 1994 and
was treated with surgical resection and postopera-
tive locoregional radiotherapy at that time. In 2002,
the patient was treated for benign anterior vertebral
body compression at T12 with percutaneous
vertebroplasty.
In April 2006, she complained of pain in her back
and left hip. Plain X-ray of the pelvis revealed a lytic
lesion within the left supra-acetabular ilium abutting
the cortex (Figure 1). A poorly defined lesion with a
non-displaced pathologic fracture was seen within the
left greater trochanter. Degenerative changes within
the lumbar spine and the symphysis pubis were also
observed. Computed tomography (CT) images of the
lumbar spine and pelvis (Figure 2) confirmed the
observations and showed that the lesion in the poste-
rior aspect of the left greater trochanter was in fact
lytic and had breached through the cortex.
For the pain in the left hip, the patient was given
a single 8-Gy fraction of palliative radiotherapy treat-
ment that, at 1 month, had produced no significant
benefit. Subsequently, the interventional radiologist
and the orthopedic surgeon both recommended per-
cutaneous cementoplasty of the left acetabulum. A
13-gauge needle [Cook M1M Osteo-Site: Cook
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(Canada), Stouffville, ON] was advanced into the left
acetabular lesion through the anterior superior iliac
spine (Figure 3). Cement (about 4.5 mL) was injected,
with good filling of the left acetabular lesion and no
extravasation. No periprocedural complications oc-
curred. The lesion in the left greater femoral tro-
chanter was left untreated.
The patient was evaluated before and after the
procedure for pain, functional status, and analgesic
intake. The patient rated pain intensity and functional
interference according to the Brief Pain Inventory
(BPI) 6. The BPI is a patient-based assessment tool that
evaluates worst, average, and current pain intensity
on a scale of 0–10, with “no pain” and “worst pos-
sible pain” as descriptive anchors. Pain interference
with functionality is measured in seven categories—
general activity, mood, walking ability, normal work,
relations with others, sleep, and enjoyment of life—
on a scale of 0–10 where 0 is no interference and 10
is complete interference. Functional status was mea-
sured using the Karnofsky Performance Scale (KPS)
and the Townsend Functional Assessment Scale
(TFAS). The KPS is widely used to assess functional
status, level of ambulation, and ability to perform self-
care in cancer patients 7–9. This 11-point scale ranges
from 0 to 100 in increments of 10 (where 0 means
“dead” and 100 means “normal”). The TFAS classifies
patients into categories according to their functional
capabilities 1: “normal; pain-free use of extremity” 2,
“normal use with pain” 3, “significant limited use”
(for example, crutches, walker, cane) 4, “non-func-
tional extremity” (for example, use of a wheelchair
or bedridden) 10.
Post-procedure, CT imaging of the pelvis and both
hips was performed (Figure 4). Note was made of
the cement that filled the lytic lesion, which extended
into the base of the left ilium. Lytic lesions in the left

FIGURE 1 Pre-procedure plain X-ray of pelvis shows a lytic lesion
within the left supra-acetabular ilium abutting the cortex.
FIGURE 2 Pre-procedure computed tomography images of the pelvis
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greater trochanter and posterior iliac margin of the
right sacroiliac joint were still observed.
The research assistant conducted post-procedure
telephone follow-up at days 1, 2, and 4, and weeks 1,
2, and 4. Repeat TFAS and BPI scores and analgesic
consumption were recorded.
3. RESULTS
Pre-procedure, the patient had a KPS score of 80, a
TFAS rating of 3, and a worst pain score of 4 in the left
acetabulum. In the 24 hours before the percutaneous
cementoplasty, the patient’s pain interfered with both
walking ability and normal work at a score of 2 on a
scale of 0–10, but it did not influence the other func-
tional interference measures (score of 0 on a scale of
0–10). The patient was taking ibuprofen 6 times daily
as needed for her osteoarthritic back pain.
Immediately post-procedure and at day 1, the
patient’s KPS, worst pain score, and functional inter-
ference remained unchanged; however, she claimed
to feel dramatically better. Her TFAS rating improved
to a 2, because she was not relying on a cane to am-
bulate. At day 2, her TFAS rating improved to a 1, and
she reported a worst pain score of 2, with a score of 0
for the seven functional interference measures. These
improved scores remained constant through the four
subsequent follow-ups. No change in analgesic con-
sumption was reported.
4. DISCUSSION
Deformation of the bone because of cancer may re-
sult in stress on the periosteum, causing pain 11. When
metastatic disease occurs in the pelvis, walking abil-
ity may become impaired, with consequential
FIGURE 3 Computed tomography–guided percutaneous cementoplasty of left acetabular lytic lesion. Good filling of the left acetabular
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influence on the patient’s quality of life. Stabiliza-
tion of the pelvic bone with cement injection often
leads to significant pain relief and improved mobil-
ity in the treated area within 24 hours.
Weill et al. reported 18 patients with acetabular
metastases treated with percutaneous cementoplasty 1.
In the first 72 hours, improvement was noted in 83%
of cases, with 61% of patients presenting total im-
provement, which was defined as the disappearance
of pain even while walking with no difference in an-
algesic medication 1. Cotton et al. recorded improve-
ment in pain in 83% of their 12 acetabular osteolytic
lesion cases 12. Both groups reported that patients with
“good filling” experienced total improvement more
often; however, no exact correlation between the de-
gree of filling of the lesion and response was
found 1,12. Other prospective studies involving per-
cutaneous cementoplasty treatment for bone lysis
(pelvis, ilium, and femur) observed almost immedi-
ate and dramatic pain relief and improvements in
ambulation for most patients 2,11,13.
These immediate improvements in pain and walk-
ing from percutaneous cementoplasty are also long
lasting. Weill et al. followed patients for an average
of 9.4 months (range: 2–48 months) with only two
incidences of pain recurrence (one at 6 months and
one at 39 months), both in keeping with local tumour
progression 1. Kelekis et al. 13 observed that signifi-
cant pain relief persisted throughout follow-up (av-
erage: 9 months; range: 2 days to 2 years) for all of
the patients who experienced immediate effects.
Marcy et al. 2 found that improvements in pain and
walking typically extended through follow-up (aver-
age: 4.6 months; range: 11 days to 24 months).
Our findings are consistent with the cases men-
tioned above. The patient experienced pain relief
very quickly (within 48 hours) and remained steady
for the remainder of the follow-up. Functional sta-
tus and interference also improved, probably as a
direct result of reduced pain and improved walking
ability.
Although pain relief and stabilization of the bone
are the most important objectives of percutaneous
cementoplasty, it is also important that complications
do not arise, because they could potentially be haz-
ardous or result in additional pain. Weill et al. 1 ob-
served cement leaks toward the soft tissue or hip joint
in 28% (n = 5) and 22% (n = 4) of patients respec-
tively. However, only 2 patients (11%) were symp-
tomatic: one from each case of complications.
Kelekis et al. 13 observed leakage into the hip joint
in one patient (7%), but that patient remained asymp-
tomatic throughout the 3-month follow-up. Another
patient (7%) had leakage into the obturator foramen,
which led to continued pain that was managed with
radiofrequency treatment of the pudendal nerve 13.
Marcy et al. 2 and Hierholzer et al. 11 reported no
major complications and no leakage into the joint
space. However, Marcy et al. 2 noted that 1 patient
(6%) experienced pain recurrence after the proce-
dure because of an acetabular fracture. Although
problems can arise, percutaneous cementoplasty ap-
pears for the most part to be well tolerated, with few
complications.
5. CONCLUSION
Osseous metastases that are resistant to traditional
conservative treatment modalities such as radiation
or medication (or both) present a significant problem
in the management of oncology patients. Surgical
procedures can be dangerous for certain subsets of
patients, and the undesirable effects may outweigh
the clinical benefits for those with a short life ex-
pectancy 2. Improvement in pain and walking ability
is essential for enhancing patient quality of life, es-
pecially for those with good performance status and
anticipated lengthier survival.
Our case echoes the literature, in that percutane-
ous cementoplasty of painful metastasis in the ac-
etabulum provides immediate and long-term pain
relief with few complications. We recommend that
this procedure be used as an additional tool for pal-
liative treatment of patients with bone metastases.
6. REFERENCES
1. Weill A, Kobaiter H, Chiras J. Acetabulum malignancies: tech-
nique and impact on pain of percutaneous injection of acrylic
surgical cement. Eur Radiol 1998;8:123–9.
2. Marcy PY, Palussière J, Magné N, et al. Percutaneous
cementoplasty for pelvic bone metastasis. Support Care Can-
cer 2000;8:500–3.
3. Sheppard S. Radiotherapy and the management of metastatic
bone pain. Clin Radiol 1988;39:547–50.
4. Gilbert HA, Kagan AR, Nussbaum H, et al. Evaluation of
FIGURE 4 Axial computed tomography images of the pelvis and both




CURRENT ONCOLOGY—VOLUME 14, NUMBER 1
radiation therapy for bone metastases: pain relief and quality
of life. AJR Am J Roentgenol 1977;129:1095–6.
5. Fallon M, McConnell S. The principles of cancer pain man-
agement. Clin Med 2006;6:136–9.
6. Daut RL, Cleeland CS, Flannery RC. Development of the
Wisconsin Brief Pain Questionnaire to assess cancer pain and
other diseases. Pain 1983;17:197–210.
7. Anderson F, Downing GM, Hill J, Casorso L, Lerch N. Pallia-
tive performance scale (PPS): a new tool. J Palliat Care 1996;
12:5–11.
8. Sorensen JB, Klee M, Palshof T, Hansen HH. Performance
status assessment in cancer patients. An inter-observer vari-
ability study. Br J Cancer 1993;67:773–5.
9. Taylor AE, Olver IN, Sivanthan T, Chi M, Purnell C. Observer
error in grading performance status is cancer patients. Sup-
port Care Cancer 1999;7:332–5.
10. Chow E, Holden L, Danjoux C, et al. Successful salvage using
percutaneous vertebroplasty in cancer patients with painful
spinal metastases or osteoporotic compression fractures.
Radiother Oncol 2004;70:265–7.
11. Hierholzer J, Anselmetti G, Fuchs H, Depriester C, Koch K,
Pappert D. Percutaneous osteoplasty as a treatment for pain-
ful malignant bone lesions of the pelvis and femur. J Vasc Interv
Radiol 2003;14:773–7.
12. Cotton A, Deprez X, Migaud H, Chabanne B, Duquesnoy B,
Chastanet P. Malignant acetabular osteolyses: percutaneous
injection of acrylic bone cement. Radiology 1995;197:307–10.
13. Kelekis A, Lovblad KO, Mehdizade A, et al. Pelvic osteo-
plasty in osteolytic metastases: technical approach under fluo-
roscopic guidance and early clinical results. J Vasc Interv
Radiol 2005;16:81–8.
Correspondence to: Edward Chow, Department of
Radiation Oncology, Toronto–Sunnybrook Regional
Cancer Centre, 2075 Bayview Avenue, Toronto,
Ontario  M4N 3M5.
E-mail: Edward.Chow@sunnybrook.ca
* Radiation Oncology, Toronto–Sunnybrook Re-
gional Cancer Centre, Toronto, Ontario.
† Medical Imaging, Sunnybrook Health Sciences
Centre, Toronto, Ontario.
‡ Orthopaedic Surgery, Sunnybrook Health Sci-
ences Centre, Toronto, Ontario.
§ Radiation Therapy, Toronto–Sunnybrook Re-
gional Cancer Centre, Toronto, Ontario.
|| Palliative Care Initiative, Sunnybrook Health
Sciences Centre, Toronto, Ontario.